Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live12-10 04:59

Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 1%.

The iShares Biotechnology ETF (IBB) fell 1.7%.

In corporate news, Mirum Pharmaceuticals' (MIRM) acquisition of Bluejay Therapeutics expands its rare liver disease pipeline with brelovitug, a hepatitis delta virus therapy that has shown "solid" phase 2 results, Morgan Stanley said in a note Tuesday. Morgan Stanley kept its overweight rating and raised its price target to $95 from $81. Mirum shares were down 3.7%.

Pfizer (PFE) said that it has signed an exclusive global collaboration and licensing deal with YaoPharma, a unit of Shanghai Fosun Pharmaceutical, to develop, make and commercialize YP05002 for chronic weight management. Pfizer shares were down 1.7%.

CVS Health (CVS) lifted its full-year outlook on Tuesday amid ongoing efforts to strengthen its core businesses, while the healthcare company said it expects earnings in 2026 to be higher than the previous year. Its shares rose 2.4%.

Teleflex (TFX) said Tuesday it agreed to sell its Acute Care, Interventional Urology and OEM units for a combined $2.03 billion in cash. Its shares jumped 9.7%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment